ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

In Brief: Switch To Grants Did Not hurt Virus Research, Watson says; The Field Is Healthy, Well Funded

October 2, 1981

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

January 15, 1993

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

Congress gives FDA authority to require pediatric clinical trials.

November 28, 2003

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974